Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study

Lancet

Volumn 358, Issue 9285, 2001, Pages 861-865

  Parle, James V ^a   Maisonneuve, Patrick ^b   Sheppard, Michael C ^a   Boyle, Peter ^b   Franklyn, Jayne A ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HAZARD; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SINUS RHYTHM; STANDARDIZATION; THYROTROPIN BLOOD LEVEL;

EID: 0035883894     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06067-6     Document Type: Article

References (17)

1. Subclinical hyperthyroidism: Just a low serum thyrotrophin concentration or something more?
2. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement
3. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine
4. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit
5. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom
6. Effects on bone mass of long term treatment with thyroid hormones: A meta-analysis
7. Cardiac effects of long term thyrotropin suppressive therapy with levothyroxine
8. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis
9. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons
10. Morbidity in patients on L-thyroxine: A comparison of those with a normal TSH to those with a suppressed TSH
11. Thyrotoxicosis and the heart
12. Thyrotoxicosis and the heart: Something old and something new
13. Mortality after the treatment of hyperthyroidism with radioactive iodine
14. Thyrotoxicosis, atrial fibrillation, and embolism, revisited
15. The nature and prognosis of heart disease in thyrotoxicosis
16. Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine
17. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine